Jérôme Fennell

1.4k citations

28 papers · 1.1k indexed · 1 hit paper · h-index 13

Co-authors: Amro Widaa Fergal J. O’Brien Emily J. Ryan Cathal J. Kearney S. K. O’Rourke Kevin C. Cahill Nicola Kavanagh Steven W. Kerrigan
Topics: Antimicrobial Resistance in Staphylococcus (8 papers)Antibiotics Pharmacokinetics and Efficacy (6 papers)Urinary Tract Infections Management (5 papers)
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Clinical Biochemistry
Journals: Clinical Microbiology Reviews Hypertension Antimicrobial Agents and Chemotherapy
Partner nations: Ireland Australia United Kingdom

In The Last Decade

Jérôme Fennell

27 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions

2018 373 citations Nicola Kavanagh, Emily J. Ryan et al. Clinical Microbiology Reviews profile →

Peers

Countries citing papers authored by Jérôme Fennell

Since Specialization

Citations

This map shows the geographic impact of Jérôme Fennell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Fennell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Fennell more than expected).

Fields of papers citing papers by Jérôme Fennell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Fennell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Fennell. The network helps show where Jérôme Fennell may publish in the future.

Co-authorship network of co-authors of Jérôme Fennell

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Fennell. A scholar is included among the top collaborators of Jérôme Fennell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Fennell. Jérôme Fennell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased rates of invasive bacterial disease in late 2022 2023 ·European Journal of Pediatrics ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),C. Myers,John Waldron,(unknown),(unknown),Jérôme Fennell,Patrick Fitzpatrick,John Fitzsimons,(unknown),David Vaughan,Kathleen M. Gorman,Robert Cunney,(unknown),Jonathan O’B Hourihane	3
2	Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directionsbreakdown → 2018 ·Clinical Microbiology Reviews ·Nicola Kavanagh,Emily J. Ryan,Amro Widaa,(unknown),Jérôme Fennell,S. K. O’Rourke,Kevin C. Cahill,Cathal J. Kearney,Fergal J. O’Brien,Steven W. Kerrigan	373
3	Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy 2017 ·Clinical Microbiology and Infection ·Catherine J. Byrne,Jason A. Roberts,Brett McWhinney,Sheila A. Ryder,Jérôme Fennell,(unknown),Evelyn Deasy,Suzanne Egan,Ronan Desmond,Helen Enright,Deirdre M. D’Arcy,Johnny McHugh	33
4	Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy 2017 ·Journal of Antimicrobial Chemotherapy ·Catherine J. Byrne,(unknown),Brett McWhinney,Jérôme Fennell,(unknown),Evelyn Deasy,(unknown),Helen Enright,Ronan Desmond,Sheila A. Ryder,Deirdre M. D’Arcy,Johnny McHugh,Jason A. Roberts	44
5	Identification badge lanyards as infection control risk: a cross-sectional observation study with epidemiological analysis 2017 ·Journal of Hospital Infection ·(unknown),Francesco Di Ruscio,Michael T. Lynskey,(unknown),(unknown),(unknown),Diana D. McDonnell,Jérôme Fennell	4
6	Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland 2016 ·BMC Infectious Diseases ·Fardod O’Kelly,Siobhán Kavanagh,Rustom P. Manecksha,John Thornhill,Jérôme Fennell	12
7	Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity 2015 ·International Journal of Antimicrobial Agents ·Catherine J. Byrne,(unknown),Jérôme Fennell,(unknown),Helen Enright,Evelyn Deasy,Sheila A. Ryder,Deirdre M. D’Arcy,Johnny McHugh	26
8	Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection 2015 ·PLoS Pathogens ·Aisling Brown,Alison G. Murphy,Stephen J. Lalor,John Leech,Kate M. O’Keeffe,Micheál Mac Aogáin,(unknown),Keenan A. Lacey,Mehri Tavakol,Claire H. Hearnden,Deirdre Fitzgerald‐Hughes,H. Humphreys,Jérôme Fennell,Willem J. B. van Wamel,Timothy J. Foster,Joan A. Geoghegan,Ed C. Lavelle,Thomas R. Rogers,Rachel M. McLoughlin	136
9	An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999–2009 2012 ·Irish Journal of Medical Science (1971 -) ·Ivor M. Cullen,Rustom P. Manecksha,(unknown),Sajjad Ahmad,Fardod O’Kelly,Robert J. Flynn,Ted McDermott,Philip G. Murphy,R. Grainger,Jérôme Fennell,John Thornhill	33
10	Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study 2012 ·BMC Infectious Diseases ·Jérôme Fennell,Akke Vellinga,Belinda Hanahoe,Dearbháile Morris,Fiona Boyle,(unknown),(unknown),(unknown),(unknown),Martin Cormican	33
11	Using Six Sigma to improve once daily gentamicin dosing and therapeutic drug monitoring performance 2012 ·BMJ Quality & Safety ·(unknown),Philip G. Murphy,Jérôme Fennell,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Tim Delaney	21
12	Reporting of meticillin-resistant and -susceptible Staphylococcus aureus on death certificates in Irish hospitals 2011 ·Journal of Hospital Infection ·(unknown),Marianne Fraher,Karen O’Connell,Jérôme Fennell,(unknown),Niamh O’Sullivan,Martin Cormican,Lynda Fenelon,Philip G. Murphy,Margaret M. Hannan	2
13	The changing pattern of antimicrobial resistance within 42 033 Escherichia coli isolates from nosocomial, community and urology patient‐specific urinary tract infections, Dublin, 1999–2009 2011 ·British Journal of Urology ·Ivor M. Cullen,Rustom P. Manecksha,(unknown),Sarfraz Ahmad,Fardod O’Kelly,Robert J. Flynn,Ted McDermott,Philip G. Murphy,Ronald G. Grainger,Jérôme Fennell,John Thornhill	57
14	Exsanguinators and tourniquets: Do we need to change our practice? 2011 ·The Surgeon ·Zubin J. Daruwalla,Fiachra Rowan,(unknown),Jérôme Fennell,M. Neligan	7
15	1365 THE CHANGING PATTERN OF ANTIMICROBIAL RESISTANCE WITHIN 42033 ESCHERICHIA COLI ISOLATES FROM NOSOCOMIAL, COMMUNITY, AND UROLOGY PATIENT SPECIFIC URINARY TRACT INFECTIONS, DUBLIN 1999–2009 2011 ·The Journal of Urology ·Ivor M. Cullen,Rustom P. Manecksha,(unknown),Ted McDermott,Robert J. Flynn,Philip G. Murphy,(unknown),John Thornhill,Jérôme Fennell	10
16	A fatal case of Pasteurella multocida epiglottitis 2009 ·Irish Journal of Medical Science (1971 -) ·Karen O’Connell,Jérôme Fennell,John T. Callaghan,(unknown),(unknown)	10
17	Hypertension : methods and protocols 2005 ·Humana Press eBooks ·Jérôme Fennell,Andrew H. Baker	11
18	Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension 2002 ·Gene Therapy ·Jérôme Fennell,Mark Brosnan,(unknown),Carlene A. Hamilton,M. Yvonne Alexander,Stuart A. Nicklin,Donald D. Heistad,Andrew H. Baker,Anna F. Dominiczak	74
19	Oxidative stress and vascular damage in hypertension 2001 ·Current Opinion in Nephrology & Hypertension ·Colin Berry,M. Julia Brosnan,Jérôme Fennell,Carlene A. Hamilton,Anna F. Dominiczak	119
20	Restoration of nitric oxide bioavailability in the SHRSP model using adenoviral-mediated gene transfer of endothelial nitric oxide synthase into an intact endothelium 1999 ·Hypertension ·M. Yvonne Alexander,Mark Brosnan,Carlene A. Hamilton,Jérôme Fennell,Howard Prentice,Timothy O’Brien,Anna F. Dominiczak	1

About Jérôme Fennell

Jérôme Fennell is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Microbiology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (42 citations), Molecular Medicine (88 citations) and Clinical Biochemistry (108 citations). Jérôme Fennell has collaborated with scholars based in Ireland, Australia and United Kingdom. Frequent co-authors include Amro Widaa, Fergal J. O’Brien, Emily J. Ryan, Cathal J. Kearney, S. K. O’Rourke, Kevin C. Cahill, Nicola Kavanagh, Steven W. Kerrigan, Carlene A. Hamilton and Anna F. Dominiczak. Their work appears in journals such as Clinical Microbiology Reviews, Hypertension and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact